All In Biotech

Drug Trial Radar · NCT00005774

Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants

Early Surfactant Followed by Nasal CPAP to Reduce the Use of Mechanical Ventilation Without Additional Morbidity in Infants 1250- 2000 Grams With RDS

Last checked: Nov 19, 2026Latest source record: Jun 8, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

61

Actual

Start

May 2000

Primary completion

Jul 2002

Study completion Jul 2002

Sponsor

Lead sponsor
NICHD Neonatal Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Center for Research Resources (NCRR)
First posted
Jun 2, 2000

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 12 hours
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Mechanical ventilation (MV) of preterm infants with respiratory distress syndrome (RDS) is associated with lung injury and nosocomial infection. Moderately premature infants with mild respiratory distress do not routinely receive artificial surfactant early in their course of treatment. This multi-center, randomized trial tested whether early surfactant therapy and nasal continuous positive airway pressure (CPAP) in infants 1,250-2,000g with RDS reduced mechanical ventilation usage without added complications. Infants with mild to moderate respiratory distress syndrome were enrolled in the trial and given either early administration of surfactant followed by extubation within 30 minutes and the use of CPAP, or standard practice (surfactant according to current center practice, only after initiation of mechanical ventilation), to see whether the experimental method would reduce the need for subsequent mechanical ventilation.

Conditions

  • Infant, Newborn
  • Respiratory Distress Syndrome
  • Respiratory Insufficiency

Interventions

  • Early surfactantDrug

    Early surfactant followed by extubation within 30 minutes and application of continuous positive airway pressure (CPAP)

  • Standard practiceDrug

    Surfactant according to current center practice, only after initiation of mechanical ventilation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Need for mechanical ventilation following randomizationTime frame: Until hospital discharge or 120 days of life

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Stanford University

    Palo Alto, California

  • Yale University

    New Haven, Connecticut

  • University of Miami

    Miami, Florida

  • Emory University

    Atlanta, Georgia

  • Indiana University

    Indianapolis, Indiana

  • Wayne State University

    Detroit, Michigan

  • University of New Mexico

    Albuquerque, New Mexico

  • Cincinnati Children's Medical Center

    Cincinnati, Ohio

  • Case Western Reserve University, Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • Brown University, Women & Infants Hospital of Rhode Island

    Providence, Rhode Island

  • University of Tennessee

    Memphis, Tennessee

  • University of Texas Health Science Center at Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.